. This difference continued throughout treatment, and at 12 months, nearly 60% FREED-AN patients returned to a BMI of 18.5 or greater. FREED shows promise as a service model for emerging adults with EDs.
| INTRODUCTION
Eating disorders (EDs) are common mental disorders, with the peak age of onset spanning adolescence and early adulthood. 1, 2 In other psychiatric disorders, intervening during early stage, first episode illness, when symptoms are likely to be more malleable, is seen as critical in promoting favourable long-term outcomes. For example, in psychosis, systematic reviews and meta-analyses support the association between a shorter duration of untreated psychosis and better clinical outcomes. 3, 4 Analogous arguments support the need for early intervention (EI) in EDs. 5 Firstly, it has long been known that in anorexia nervosa (AN) illness duration is a key predictor of outcome. 6 Secondly, growing evidence suggests that EDs are associated with significant structural and functional brain changes. 7, 8 As the typical age of ED onset is during a period, when prefrontal brain areas important in self-regulation are developing, 9 this has the potential to interfere with normal brain development. Thirdly, it has been recognised across different psychiatric disorders that with increasing duration, the illness becomes more entrenched and difficult to change. This is proposed to arise from "neuroprogression," ie, neurobiological changes that alter the trajectory of illness. 10, 11 In EDs, converging neuroimaging and cognitive neuroscience data support this idea. [12] [13] [14] Finally, given the high physical, psychosocial, and financial burden of EDs, treating
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symptoms early is valuable from both an ethical and economical perspective. 5 Stage-of-illness-based ED models incorporate these ideas and findings and suggest that stage-appropriate EI may be able to halt illness progression. 5, 15 In England, a government-led EI initiative has introduced specialist ED community teams together with waiting time standards for young people below the age of 18. 16 This initiative is grounded in concerns that across different countries, hospitalisations of young people with AN are rising. 17 Studies of hospitalisation trends from the 1960s to the present have shown large recent increases in hospitalisation rates in England, with the greatest rise in young women aged 15 to 19. 18 In contrast, admission rates for most other mental disorders have declined. 19 Pilot data suggest that in areas where specialist ED adolescent outpatient services are available, rates of hospitalisations are significantly lower. 20 However, this initiative only covers part of the United Kingdom. Moreover, it does not cover emerging adults, who are aged 18 to 25, have a high incidence of EDs, and like adolescents, face multiple developmental challenges. 21 Taken together, there is a strong rationale for EI for EDs but a lack of research. This led us to propose an EI service model for emerging adults with early stage EDs. 2 Our model is biopsychosocial, with a focus on optimising early care. A pilot evaluation of this First Episode Rapid Early Intervention service for ED (FREED) found significantly reduced waiting times and duration of untreated ED. 22 The present study (1) assesses ED and other clinical outcomes in FREED patients and their carers, (2) compares FREED service utilisation to that of comparable patients seen previously in our service, and (3) compares body mass index (BMI) change in FREED AN patients and comparable AN patients seen previously. to inform decisionmaking), factors that precluded completing questionnaires (severe learning disability and inability to speak English), not being available for the 12-month duration of the study, and/or the presence of a primary comorbid physical/ mental disorder requiring priority treatment (eg, substance dependence). All other comorbid patients were treated within the study.
| MATERIALS AND METHODS

| Audit cohort
To have a comparison group, we carried out an audit of patients seen in our service during the 2 years prior to implementation of FREED. All patients referred during mid-May 2012 to mid-May 2014 who were aged 18 to 25 were identified from clinical records. Information regarding ED onset was obtained from clinical assessment letters. Those with an illness duration ≤3 years were included.
| Procedures
| Clinical procedures
Details of the FREED service model and care pathway are described elsewhere ( 2, 22 ). Briefly, all referrals for individuals aged between 18 and 25 years are screened by telephone (within 48 h of referral). All telephone screenings were carried out by an ED clinician working in the outpatient service with the role of "FREED champion." Patients deemed eligible for FREED (and where there are no gate-keeping arrangements restricting access to care) are immediately booked into the next available assessment (aiming for <2 weeks from date referral received). Each screening call took approximately 15 minutes to complete. The standard ED assessment protocol used in the service was adapted for FREED clinical assessments; ie, it consists of a biopsychosocial, personcentred assessment, which considers the young person within their family and social context, focusing on their needs, priorities, and strengths. Where possible, family members and close others join part of the assessment.
Attention is paid to the young person's use of social media and health-related apps, given ubiquitous use of these amongst young people, and their known role in maintaining ED symptoms. 24 
| Research procedures FREED cohort
Patients (and where appropriate, their carers) entered into the FREED service were invited to participate in the FREED service evaluation study at assessment and were required to give their written, informed consent. Following this, patients and, where possible, their carers completed the first of 4 questionnaire packs. This time point is referred to as "baseline." Participants and carers were asked to complete similar questionnaires packs at 3, 6, and 12 months following the initial assessment. Patients were followed up irrespective of whether they completed treatment.
Audit cohort
For patients in the audit cohort, their referral, assessment, and service usage data (number of outpatient sessions attended; additional in-patient or day-care treatment during the year following assessment) were extracted from their clinical notes. For AN patients, BMI data were also extracted from the notes (where possible) within 1 month of each of the 4 time points used in FREED. Questionnaire data were not available for the audit cohort at FREED-comparable time points.
| Outcomes
| Process outcomes
The waiting time for treatment was defined as the time period (in weeks) from the date the referral was made (eg, by the general practitioner) to the date patients attended their first treatment session. The waiting time (in weeks) between assessment and treatment was also calculated. Treatment uptake was defined as attending a minimum of 1 treatment session after assessment. Service utilisation was also assessed in total number of treatment sessions attended, and the need for additional intensive treatment (ie, day-care or inpatient treatment) during the year following assessment.
| Clinical outcomes Psychological measures
Eating Disorder Examination Questionnaire Version 6 of the Eating Disorder Examination Questionnaire (EDE-Q) 27 was completed by patients. Questions relate to the past 28 days and are measured on a 7-point Likert scale ranging from 0 (no days) to 6 (every day). Four subscale scores (restraint, eating concern, shape concern, and weight concern) are calculated and based on these a global score. High global scores indicate greater ED psychopathology, with a proposed clinical cut-off score of ≥2.8.
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Ten-item version of Clinical Outcomes in Routine Evaluation A short, 10-item version of the Clinical Outcomes in Routine Evaluation (CORE-OM) was completed by both patients and carers. 29 The CORE-10 is a measure of global distress and functioning. Each item is rated on a 5-point Likert scale from "not at all" (0/4) to "most or all of the time" (4/0). The clinical score is calculated by adding the values of all 10 items. Scores below 10 are deemed nonclinical, whilst scores of 11 or above are within the following clinical ranges: 11 to 15 mild, 15 to 20 moderate, 20 to 25 moderate/severe, and >25 severe.
Depression, Anxiety, and Stress Scale 21 The Depression, Anxiety, and Stress Scale 21 (DASS-21), completed by both patients and carers, is a short version of a 42-item self-report measure that assesses mood state over the past 7 days. 30 It is comprised of 21 items measured on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much, or most of the time). Each item loads on to 1 of 3 subscales, depression, anxiety, and stress, which when added together provide a total score indicative of general psychopathology. A normative baseline cut-off of 13 for the total DASS-21 score has been proposed, 31 and high scores indicate worse symptomatology.
Work and Social Adjustment Scale The Work and Social Adjustment Scale was completed by both patients and carers. It is a 5-item self-report scale designed to measure functional impairment attributable to an identified problem, in this case an ED. 32 Each item is rated on a 9-point Likert scale ranging from "no impairment" (0) to "very severe impairment" (8) . The maximum total score is 40. Scores above 20 suggest moderate-severe psychopathology, scores 10 to 20 indicate less severe clinical impairment, and scores below 10 are deemed subclinical.
Clinical Impairment Assessment The 22-item Clinical Impairment Assessment (CIA) was completed by patients. It is a self-report measure of the severity of psychosocial impairment due to ED features. 33 The CIA focuses on the past 28 days, and the 22 items cover impairment in domains of life typically affected by ED psychopathology, eg, mood, self-perception, cognitive functioning, interpersonal functioning, and work performance. Each item is rated on a 4-point Likert scale ranging from "not at all" (0) to "a lot" (3) . A global CIA impairment score is calculated by adding all items together and dividing by the total number of items completed. Global CIA scores range from 0 to 3, with a higher score indicative of greater secondary psychosocial impairment.
Level of Expressed Emotion Scale Patient and carer versions of the Level of Expressed Emotion Scale (LEE)
were completed in the current study. The LEE aims to measure the perception of expressed emotion in a person's influential relationships. Both versions of the LEE include 60 items with the option of a "true" or "false" response. 34 An overall score is generated by summing the 38 items, with a higher score indicative of greater perceived expressed emotion.
Accommodation and Enabling Scale for Eating Disorders The Accommodation and Enabling Scale for Eating Disorders is a 33-item self-report measure that aims to assess accommodating and enabling behaviours of ED carers. 35 Each item is rated on a 5-point Likert scale from "never/no" (0) to "everyday/extreme" (4), with the exception of item 24 that is transformed into a 5-point Likert scale. A total score is calculated by summing the score on all items. A higher score is associated with higher accommodation of ED symptoms.
Weight and body mass index (BMI)
Patients' weight and height were measured, and their BMI (kg/m 2 ) was calculated. These data were taken from clinical notes nearest to the date of the 4 time points (approximately 1 month from the baseline, 3-month, 6-month, and 12-month measurement points) that questionnaires were completed. In addition, BMI at the start of treatment was also taken.
| Statistical analyses
Overall, our analyses followed the recommendations of the Child Outcome Research Consortium (CORC) for service data. 36 The CORC suggestion is to provide accessible descriptive analyses first and foremost, and only undertake statistical tests where there is a clear reason to do so. With this in mind, statistical analyses followed from the 3 study aims. Firstly, there was a within-group evaluation of the clinical outcomes for the FREED group. To estimate within-group changes in the whole FREED cohort over the course of treatment, linear mixed models were used. Change was estimated by using time as a fixed categorical factor (baseline, 3, 6, and 12 months) with correlations within patient repeated measures accounted for by inclusion of a random intercept for participant and slope to allow change over time to vary by person. Changes from baseline to 3, 6, and 12 months and 6 to 12 months were calculated with P values and confidence intervals Bonferroni adjusted for multiple comparisons. Using mixed models for the analysis fit with maximum likelihood allows missing data to be included in model estimates under the assumption that the data were missing at random. Predictors of missingness such as diagnosis, age of onset, treatment completion, gender, ethnicity, and BMI at assessment were examined. Only diagnosis was found to be a predictor of missingness and was therefore included in the mixed model as a covariate.
Secondly, the relative impact of FREED on process outcomes was evaluated by comparing the FREED cohort with the audit cohort, constructed from eligible patient notes from the period May 2012 to May 2014 inclusive. Between-group demographic and clinical baseline features were compared with t-tests, chi-square tests, or Fisher's exact tests as appropriate. Group differences in process outcomes and in particular waiting-times and total number of sessions attended were analysed by using a generalised linear model with negative binomial errors. Proportions were also calculated to compare intensive treatment usage for FREED and the audit group and carer involvement within the FREED group.
As indicated above, the only clinical information available for the audit group was BMI, which was collected from patient records. Thus, in the third and final part of the analysis, we compared change in BMI for FREED and audit patients with an AN diagnosis. To do this, we fitted a linear mixed model with measurement time point (baseline, 3, 6, and 12 months) and group (FREED vs audit) as main effects and a group by time point interaction. As for the within group analysis, predictors of missing data were sought but none were identified. Statistical analyses were performed by using IBM® SPSS® software (Version 23) and Stata version 14.1 IC. Figure 1 shows the participant flow through the study. Nine "FREED pilot cases" were referred before the study period (ie, prior to September 2014) but treated under the FREED service model. These 9 cases were not included in the process outcomes we previously reported. 22 However, as they received clinical care within the FREED service, we have included them in all outcomes reported here. This left a total of 56 patients in the current FREED sample. Nineteen carers (relating to 19 patients) provided longitudinal data. In the audit sample (N = 86), 22/86 patients only attended an initial assessment and did not take up the offer of further treatment within the outpatient service. Therefore, the number of audit patients with outcomes after initial assessment are N = 64. Abbreviations: AN, anorexia nervosa; BN, bulimia nervosa; BED, binge eating disorder; OSFED, other specified feeding or eating disorder.
| RESULTS
| Participant flow
| Baseline characteristics
in the FREED and audit groups regarding age at referral, age of ED onset, sex, or ED diagnoses (P values between .647 and .93).
| Clinical outcomes in FREED cohort
3.3.1 | Eating disorder symptoms: Figure 2A shows EDE-Q estimated means for the whole FREED cohort across time. Raw data for all patient and carer clinical outcomes are shown in Table 2 . In the patient data, internal consistency assessed with Cronbach's alpha at baseline was excellent (ie, 0.9 ≤ α) for the EDE-Q (α = .916), DASS (α = .935), LEE (α = .95), and CIA (α = .936) and good (ie, 0.8 ≤ alpha < .9) for CORE (α = .844) and WASA (α = .844). In the carer data, internal consistency assessed was excellent (ie, 0.9 ≤ alpha) for the DASS (α = .925), WASA (α = .949) and Accommodation and Enabling Scale for Eating Disorders (α = .904) and good (ie, 0.8 ≤ alpha < 0.9) for the CORE (α = .809) and acceptable (ie, 0.7 ≤ alpha < 0.8) for the LEE (α = .759). Table 3 shows estimated changes between baseline and follow-up assessment points. From this, it can be seen that all EDE-Q follow-up time points differ significantly from baseline (T1) and that significant improvements occur between baseline (T1) and 3 months (T2) and 3 months (T2) and 6-month (T3) assessments. Table 3 also shows estimated changes from baseline for all other patient and carer questionnaire outcomes and for patient BMI collected within the whole FREED cohort at baseline, 3, 6, and 12 months.
| Other patient and carer outcomes
Patient scores were generally improved from 3, 6, and 12 months compared to the start of treatment. Change between 6 and 12 months (when people had mainly finished treatment) was generally small showing slight benefit or loss. This indicates improvement of general psychopathology, secondary psychosocial impairment, and expressed emotion, respectively. Nineteen carers provided questionnaires. Interestingly, carer scores showed strong improvements at 12 months but with most of the change in scores occurring between 6 and 12 months. There was improved general psychopathology, expressed emotion, and less accommodation of ED symptoms in carers of patients in the FREED service. 
| Treatment usage
| Carer involvement
Nearly 61% (60.7%; 33/56) of carers had some type of involvement in the treatment. This included attending : total score of 13 is normative baseline; Work and Social Adjustment Scale (WSAS): >20 moderatesevere, 10-20 moderate, and <10 subclinical; higher scores on the Level of Expressed Emotion (LEE) indicative of greater perceived expressed emotion (no severity score ranges available); higher scores on the Clinical Impairment Assessment (CIA) indicative of worse secondary psychosocial impairment (no severity score ranges available); and higher scores on the Accommodation and Enabling Scale for Eating Disorders (AESED) indicative of higher accommodation to ED symptoms (no severity score ranges available). 
| DISCUSSION
This study investigated the impact of a novel EI service on the clinical outcomes of patients with EDs and their carers and also examined the impact of the service on treatment usage.
Within the whole transdiagnostic FREED cohort, there were significant and large reductions in ED psychopathology over time, as measured by the EDE-Q. Moreover, the percentage of individuals with scores below the clinical cut off of the EDE-Q (<2.8) increased from 18% at the start of treatment to 70% at 12 months after starting of treatment. These findings are comparable to those found under optimal conditions in recent research cohorts and large-scale clinical trials, such as the UK-Italy change between FREED and audit patients found a consistent difference in BMI between the groups from start of treatment to 12 months follow-up. Of note whilst the BMI of FREED-AN patients increased between initial assessment and start of treatment, there was a decrease in the BMI of the audit cohort. This observation is important for two reasons. Firstly, the audit cohort waited significantly longer to start treatment compared with the FREED cohort. The decrease in BMI seen in the audit cohort supports the idea that waiting for treatment is detrimental for patients. Secondly, the slight increase in BMI observed in the FREED cohort could be because of the positive impact of certain core components of the FREED assessment, such as the motivational and engaging style, use of psycho-education, and emphasis on illness malleability. These are key elements to the FREED model, and they are likely to increase patient motivation in this targeted age group and led to improved engagement and outcomes. In both the FREED and the audit cohort, few patients needed additional intensive treatment (FREED 8.9% and audit 14.06%), i.e., slightly favouring FREED. Against a background of national and international trends of rising numbers of hospitalisations in young people with AN, this is promising. It is also important as intensive treatments, such as in-patient or day-care treatment, are a significant financial burden to health services and far more costly than outpatient treatment. 17, 42 Reducing the likelihood of the need for intensive treatments may also impact on downstream costs, as previous inpatient or intensive treatments are a strong predictor of relapse in EDs. 43 If the FREED service is able to target emerging adults in their first illness episode, it may be able to disrupt the course of illness, preventing the need for future costly treatment. A significant proportion of potentially eligible patients (n = 50) could not be included into the study for a variety of reasons, such as not being available for treatment due to moving away or travelling or simply not responding to our efforts to contact them after referral. This highlights the transient nature, high mobility, limited treatment motivation, and thus vulnerability of the emerging adult population for whom the FREED service was designed. This suggests that additional alternative avenues for engaging with these young people, e.g., via electronic and mobile health tools, may be necessary.
This study has several limitations that should be noted. Firstly, as the audit comparison group was collected retrospectively, it was only possible to report BMI data as an outcome. Secondly, there was a high proportion of missing self-report data at the follow-up stages in the FREED cohort. Although this is disappointing, it is still important to report this information. The UK CORC acknowledges the difficulties with collecting service data and comments that although such data are often Flawed, Uncertain, Proximate and Sparse, they should still be shared as this is likely to prompt dialogue between key stakeholders and improves care. 36 Furthermore, because of the limited number of participants in the study, it was not possible to analyse the data for each of the ED diagnoses separately, or in relation to different treatments received. We hope that we will be able to provide this information in our future studies.
This study is the first report of clinical outcomes of an EI service within the ED field. One other study has recently reported on the impact of EI in first episode AN. 44 The intervention comprised a comprehensive public health intervention implemented across the Hamburg metropolitan area. Patients recruited before and after introduction of the intervention were compared on (a) mean duration of untreated illness until specialist treatment and (b) mean duration of illness until first contact with the health service. Mean duration of untreated illness was 36.5 months before the implementation of the intervention and remained unchanged thereafter (40.1 months). Mean duration until first contact with the health service was 25.0 months before introduction of the intervention and 32.8 months thereafter, suggesting that help-seeking patients face very considerable delays in the German health care system, until they reach specialist care. Clinical outcomes are not reported in the German sample. In this study, baseline demographic and clinical features were very similar to those in our sample, but a much higher proportion of patients in the German sample (55.9% preintervention and 83.3% postintervention) were treated as in-patients. 44 In our study, duration of untreated illness for adult patients was 19.1 months and for FREED patients was 16.4 months. Duration of illness till first contact with health services was 16.2 months for audit patients and 15.7 months for FREED patients. 22 When seen in the context of the German data, our process outcomes and clinical outcomes are encouraging and support further evaluation and wider implementation of FREED. The scalability of the FREED service is now being evaluated across several specialist ED services within the UK NHS, with the aim of assessing whether FREED is a suitable national model of service delivery.
